A strategic Hospitex’ milestone: exclusive distribution agreement with Menarini Diagnostics

Florence, June 6, 2025

 

Hospitex International has signed an exclusive distribution agreement with Menarini Diagnostics, the leading European distributor of IVD and pathology solutions.
Under this agreement, Menarini will distribute throughout the Italian market:
• FISH technologies manufactured in the US by Ikonisys, for second-level molecular diagnostics;
• The full Hospitex product portfolio, including liquid-based cytology, cell block technology, and rapid immunohistochemistry.

This integrated and complementary offering will enable anatomical pathology laboratories to access a comprehensive range of solutions – from morphological to molecular analysis.

The Italian market for cytology and cell block products is estimated at around €28 million annually. This partnership strategically positions Hospitex to capture a significant share within the next three years.

Francesco Trisolini, CEO of Hospitex, commented: “With Menarini, we have identified a strong and capable partner. This collaboration will expand access to our technologies, accelerate the development of new diagnostic solutions, and enhance our contribution to cancer diagnostics.

For the official Press Release, read it on Aliko Scientific website

https://hospitex.com/wp-content/uploads/2025/06/Blog-News-25-06-06-1.webp
https://hospitex.com/wp-content/uploads/2025/02/Logo-Hospitex-International-Footer.jpg

DISCOVER OUR GROUP

CONTACTS

Hospitex International S.r.l.
Via Massimo D’Antona, 17, 50019 Sesto Fiorentino, FI – Italy

VAT N. IT07345680487
REA N. 697096

Phone: +39 055 013 5766
Email: info@hospitex.com

Copyright by Hospitex International. All rights reserved.